Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.
暂无分享,去创建一个
Glyn Johnson | Meng Law | Matilde Inglese | James S Babb | Edmond A Knopp | G. Johnson | J. Babb | M. Inglese | E. Knopp | D. Zagzag | M. Law | David Zagzag | E. Wang | Sarah Oh | Edwin Wang | Sarah Oh | G. Johnson
[1] J. Piepmeier,et al. Low-grade gliomas: Introduction and overview , 1997, Journal of Neuro-Oncology.
[2] B. Fisher,et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A Leviton,et al. Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors , 2000, Cancer.
[4] G Johnson,et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.
[5] Chun-Jung Juan,et al. Discrepant MR spectroscopic and perfusion imaging results in a case of malignant transformation of cerebral glioma. , 2002, AJNR. American journal of neuroradiology.
[6] Michael H Lev,et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. , 2004, AJNR. American journal of neuroradiology.
[7] E F Halpern,et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.
[8] B. D. Ward,et al. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. , 2004, AJNR. American journal of neuroradiology.
[9] Glyn Johnson,et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. , 2002, Radiology.
[10] M. Bernstein,et al. The Role of Surgery in Low Grade Gliomas , 1999, Journal of Neuro-Oncology.
[11] Mark S. Cohen,et al. Contrast agents and cerebral hemodynamics , 1991, Magnetic resonance in medicine.
[12] J. Piepmeier,et al. Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres. , 1987, Journal of neurosurgery.
[13] L. Astrakas,et al. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors , 2004, Cancer.
[14] D. Pickuth,et al. The management of histologically unverified presumed cerebral gliomas with radiotherapy. , 1994, International journal of radiation oncology, biology, physics.
[15] Douglas C. Miller,et al. Treatment and Survival of Low-Grade Astrocytoma in Adults--1977–1988 , 1992 .
[16] H. Mehdorn,et al. Glioblastoma multiforme-report of 267 cases treated at a single institution. , 2005, Surgical neurology.
[17] Mitchel S. Berger,et al. Low grade gliomas: Functional mapping resection strategies, extent of resection, and outcome , 1997, Journal of Neuro-Oncology.
[18] Glyn Johnson,et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.
[19] Jin-Suh Kim,et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. , 2002, AJR. American journal of roentgenology.
[20] B. Rosen,et al. Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.
[21] Glyn Johnson,et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. , 2004, AJNR. American journal of neuroradiology.
[22] M Takahashi,et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. , 1998, AJR. American journal of roentgenology.
[23] M. Prados,et al. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.